April 2026 Empty Capsules Market Update: HPMC Growth, Supply Chain Shifts, and Manufacturing Innovation

Empty capsules market hits $3.5B in 2026. HPMC capsules lead at 10%+ CAGR, Asia-Pacific manufacturing rises, AI transforms production quality.

1. Global Empty Capsules Market Surges Past $3.5 Billion

The global empty capsules market continues its robust expansion in 2026, with industry analysts projecting the market to surpass $3.5 billion by year-end. Driven by increasing pharmaceutical production, growing nutraceutical demand, and the rise of personalized medicine, the market is experiencing a compound annual growth rate (CAGR) of approximately 7-8%.

Gelatin capsules remain the dominant segment, accounting for approximately 75% of total production. However, the shift toward plant-based alternatives is accelerating, with HPMC (hydroxypropyl methylcellulose) capsules gaining significant market share across both pharmaceutical and nutraceutical applications.

Zhejiang Yuexi Capsule Co., Ltd., with nearly 40 years of manufacturing expertise and 16 fully automated production lines producing 80-110 billion capsules annually, is strategically positioned to capitalize on this market growth. The company's commitment to GMP-compliant manufacturing and ISO 9001 certification ensures consistent quality at scale.

2. HPMC Vegetable Capsules: The Fastest-Growing Segment

HPMC vegetable capsules have emerged as the fastest-growing segment in the empty capsules market, with growth rates exceeding 10% CAGR. This surge is driven by several converging factors: increasing consumer demand for vegetarian and halal-certified products, regulatory preferences for plant-based excipients in certain markets, and the superior moisture stability of HPMC capsules compared to traditional gelatin.

Key pharmaceutical companies are reformulating existing products to accommodate vegetarian capsule demand. The nutraceutical sector, in particular, has been a major catalyst, as consumers increasingly prefer plant-based supplements. HPMC capsules offer additional advantages including low moisture content (ideal for hygroscopic formulations), resistance to cross-linking, and compatibility with a wider range of fill materials.

Yuexi Capsule has been at the forefront of this trend, expanding its HPMC vegetable capsule production capacity to meet surging global demand. The company's HPMC capsules meet stringent international quality standards and are available in multiple sizes (00# through 4#), catering to diverse formulation requirements.

3. Supply Chain Realignment: Asia-Pacific Manufacturing Advantage

The pharmaceutical supply chain continues to undergo significant realignment in 2026. Geopolitical tensions and logistical challenges have prompted many international pharmaceutical companies to diversify their sourcing strategies, increasingly turning to Asian manufacturers for capsule supply.

China's capsule manufacturing sector has emerged as a key beneficiary of this shift. With competitive production costs, advanced manufacturing capabilities, and improving quality standards, Chinese capsule manufacturers are securing contracts that previously went to European or American suppliers. The Asia-Pacific region is projected to exceed North America in capsule consumption by 2028.

Yuexi Capsule, located in the Ruao Industrial Park of Xinchang County, Zhejiang Province, has leveraged its strategic position to serve over 110 overseas markets. The company's proximity to major shipping ports and established logistics networks enables efficient delivery to customers worldwide, with typical lead times significantly shorter than competitors in other regions.

4. Technology-Driven Manufacturing: AI and Automation Transform Capsule Production

The capsule manufacturing industry is undergoing a technological transformation. AI-powered quality inspection systems, automated production lines, and smart manufacturing protocols are becoming standard across leading facilities, dramatically improving both output and quality consistency.

Advanced capsule inspection systems utilizing machine vision can now detect defects as small as 0.1mm at speeds exceeding 100,000 capsules per hour. These systems, combined with real-time process monitoring and AI-driven predictive maintenance, are reducing defect rates to below 0.01% while increasing overall equipment effectiveness (OEE) by 15-20%.

Yuexi Capsule operates 16 fully automated production lines equipped with GMP-compliant manufacturing systems. The company's investment in automation and quality control technology ensures that every capsule meets the highest international standards, from raw material verification through final product inspection.

5. Enteric-Coated and Sustained-Release Capsules: Innovation in Drug Delivery

Specialty capsule segments are experiencing accelerated growth, particularly enteric-coated and sustained-release formulations. The global enteric-coated capsules market is expanding at over 9% CAGR, driven by the proliferation of drugs requiring targeted intestinal delivery and the booming GLP-1 receptor agonist market.

Enteric-coated capsules, which resist stomach acid and dissolve in the intestinal tract, are seeing increased adoption for proton pump inhibitors, enzymes, and GLP-1 analogs. Sustained-release capsules enable controlled drug release over extended periods, improving patient compliance and therapeutic outcomes.

Yuexi Capsule offers a comprehensive range of specialty capsule solutions, including enteric-coated capsules in multiple color configurations (such as green-yellow, blue-red, and medicinal brown-yellow) and sustained-release formulations. The company's custom printing services further enable pharmaceutical brand differentiation and anti-counterfeiting measures.

About Zhejiang Yuexi Capsule Co., Ltd.

Founded in 1986 and formally established in 1998, Zhejiang Yuexi Capsule Co., Ltd. is one of China's leading manufacturers of empty capsules. Operating from the Ruao Industrial Park in Xinchang County, Zhejiang Province, the company maintains 16 fully automated production lines with an annual capacity of 80-110 billion capsules across sizes 00# through 4#.

The company's product portfolio includes gelatin empty capsules, HPMC vegetable capsules, enteric-coated capsules, sustained-release capsules, and custom-printed capsules. With GMP compliance, ISO 9001 certification, and High-Tech Enterprise status, Yuexi Capsule serves customers in over 110 countries worldwide.

For more information, visit

www.yuexicapsule.com

or contact +86-575-86780222.

Source: Grand View Research, MarketsandMarkets, Fierce Pharma, April 2026